Both insurers are actively shifting from market-linked to guaranteed products and recalibrating margins impacted by ...

Private sector insurance major HDFC Life has staged a strong financial performance for the first quarter of the current ...

HDFC Life Insurance Company reported a 14% YoY jump in Q1 FY26 profit to Rs 546 crore and a 16% rise in net premium income.

HDFC Life Insurance Q1 FY26 Results, HDFCLIFE Share Market News: Mumbai-headquartered insurance provider HDFC Life has ...

HDFC Life reported a 14.5% rise in consolidated net profit to ₹546 crore for Q1FY26, driven by strong APE growth of 12.5% and ...

HDFC Life posted a 14.2 per cent year-on-year (Y-o-Y) rise in net profit to ₹546 crore in Q1FY26, supported by a 19 per cent ...

Shares of HDFC Life will be in focus on July 16 after the private insurer posted stable June quarter performance. Brokerages ...

HDFC Life Insurance Co Ltd (NSE:HDFCLIFE) reports robust growth in key metrics despite facing market competition and regulatory changes.

Earnings: Weak Numbers For Insurance Co, What's The Expansion Plan? | Vibha PadalkarHDFC Life’s Q1 earnings were underwhelming, Vibha Padalkar confirms. Growth slowed due to subdued premium inflows ...

HDFC Life reports ₹546 crore net profit in Q1FY26, up 14.2% YoY, aided by 19% rise in renewal premiums and steady VNB margins ...

Biocon Biologics, a subsidiary of Biocon, has received approval from the US FDA for KIRSTY (Insulin Aspart-xjhz), 100 units/mL, marking it as the first and only interchangeable biosimilar to NovoLog ...

HDFC Life Insurance reported APE of Rs 32.3 billion (in-line) in Q1 FY26, up 13% YoY, driven by 13%/12% YoY growth in ...